Wednesday, 02 July 2003
Last Updated Tuesday, 28 October 2003
What
Evan’s Syndrome is a combination of two conditions: autoimmune hemolytic anemia and autoimmune thrombocytopenia purpura. Autoimmune hemolytic anemia is a condition in which there are low levels of iron in the body due to the destruction of the red blood
cells that normally carry oxygen. Autoimmune thrombocytopenia is a low level of
platelets in the blood due to their destruction in the circulation.
platelets are a component of blood that is responsible for creating clots in the body to heal wounds.
Who
The
incidence of Evan’s syndrome is not precisely known. The syndrome is reported to be a complication affecting 4-10% of those persons with a particular type of thrombocytopenia known as autoimmune thrombocytopenia purpura. The syndrome is more prevalent in children than in adults.
Signs and Symptoms
The signs and symptoms of Evan’s syndrome will be a combination of the signs and symptoms of the two underlying conditions.
In autoimmune thrombocytopenia purpura the following may be found:
Bleeding of skin or mucus lined areas of the body. This may show up as bleeding in the mouth, or purpuric rashes (look almost like bruises), or tiny red dots on the skin called petechiae.
Laboratory results will show low levels of
platelets
In autoimmune hemolytic anemia the following may be found:
Fatigue
Pale skin color
Shortness of breath
Rapid heartbeat
Dark urine
Possible Causes
The cause of the signs and symptoms of Evan’s syndrome are directly related to the low levels of red blood
cells (RBC) and
platelets in the blood. These low levels are a result of circulating antibodies that bind to the blood
cells and destroy them. Antibodies are made under normal conditions against foreign substances in the body and are therefore very useful in warding off infection. In conditions that are referred to as “autoimmune” the body makes antibodies against itself. In the case of Evan’s syndrome, it is not currently known what triggers this reaction to happen.
Diagnosis
The diagnosis of Evan’s syndrome is based primarily on laboratory findings as well as the corresponding physical signs and symptoms. A complete blood count (CBC) will confirm the presence of anemia and low
platelets. Additional studies may include a peripheral smear of the blood which may reveal evidence of red blood cell destruction or reticulocytosis, and a coombs test. Reticulocytes are immature red blood
cells and are usually abundant in Evan’s syndrome where there is a need to replace ongoing losses. A coombs test is used to detect the presence of antibodies against the RBC and is usually positive. There are also distinct shapes to certain
cells that may be found when a sample of the patient’s blood is viewed under a microscope. In patients with Evan’s syndrome the red blood
cells may appear small and globular shaped (then called spherocytes) but will not be fragmented.
Treatment
The treatment for Evan’s syndrome will involve close monitoring of
hemoglobin and platelet counts. To increase the number of
platelets and RBCs in the blood, the patient may be given a corticosteroid such as prednisone. Prednisone will reduce the destruction of the
platelets and the RBCs. A certain level of prednisone may need to be taken for the child’s entire life to prevent the levels of
platelets and RBCs from dropping. Further treatment may be necessary with
immune system suppressing drugs to block the production of the antibodies. To specifically treat the anemia of the syndrome, it may be necessary to provide the child with new RBCs by a blood transfusion. It has not been shown to be effective to transfuse
platelets in a similar fashion to treat the thrombocytopenia. In more severe cases that are unresponsive to treatment, it may become necessary to remove the spleen. The spleen is the organ that is responsible for removing the
platelets and RBCs from circulation in the blood once they have been marked with the antibodies. A person can live a normal life without his spleen but needs to avoid injury as much as possible.
Prognosis
Given the fact that the signs and symptoms of this disease are related directly to the abnormal laboratory findings, the prognosis depends on the patient’s response to treatment. Spontaneous remissions of each of the individual component conditions have been reported. If the child responds well to the treatment and the levels of
platelets and red blood
cells increase, the child can expect to live a normal life. Medications will be needed life long, and laboratory tests will need to be constantly monitored to detect any abnormal changes so that treatment can be adjusted.
Connect with other parents
In the spirit of community and support, Madisons Foundation offers the unique service of connecting parents of children with rare diseases. If you would like to be connected to other parents of children with this disease,
please fill out this brief form.
Weblinks
Yahoo Groups
This is a support group for patients with Evan’s syndrome. It may be a good place to start given the rare incidence of this syndrome.
Evan's Syndrome
A website with information about the diease as well as links to other resources.
Clinical Trials.gov
A website dedicated to providing information about ongoing clinical trials.
Google Search for Evan's Syndrome
References and Sources
groups.yahoo.com/group/evans_syndrome/
www.rarediseases.org
autoimmune.pathology.jhmi.edu/diseases.cfm?systemid=5